A.R.T. Advisors, LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 98 filers reported holding ENDOLOGIX INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2018$63,000
-33.0%
33,155
+99.3%
0.00%
-25.0%
Q2 2018$94,000
+42.4%
16,633
+34.2%
0.00%
+33.3%
Q4 2017$66,000
-91.4%
12,398
-92.8%
0.00%
-92.3%
Q3 2017$767,000
-2.4%
172,192
+6.4%
0.04%
-7.1%
Q2 2017$786,000
+50.6%
161,791
+124.4%
0.04%
+75.0%
Q1 2017$522,000
-73.2%
72,100
-63.4%
0.02%
-73.9%
Q4 2015$1,951,000
+890.4%
197,109
+1605.7%
0.09%
+1214.3%
Q1 2015$197,000
-32.1%
11,556
-48.8%
0.01%
-53.3%
Q1 2014$290,000
-68.5%
22,574
-57.3%
0.02%
-69.4%
Q4 2013$921,000
+54.8%
52,856
+43.2%
0.05%
+53.1%
Q3 2013$595,000
-4.0%
36,914
-21.0%
0.03%
+60.0%
Q2 2013$620,00046,7240.02%
Other shareholders
ENDOLOGIX INC shareholders Q4 2018
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$62,127,0007.14%
Essex Woodlands Management, Inc. 1,257,468$24,875,0004.49%
First Light Asset Management, LLC 304,602$4,673,0002.20%
ArrowMark Colorado Holdings LLC 3,464,775$53,150,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,449,897$37,581,0001.25%
Iguana Healthcare Management, LLC 200,000$3,068,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,262,0000.71%
PALISADE CAPITAL MANAGEMENT, LP 1,651,798$25,339,0000.64%
PERKINS CAPITAL MANAGEMENT INC 34,200$525,0000.46%
CADIAN CAPITAL MANAGEMENT, LP 967,443$14,841,0000.44%
View complete list of ENDOLOGIX INC shareholders